AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT /

Gelijkaardige items

• IDENTIFICATION OF ANTICANCER DRUG THROUGH STUDYING THE ACTIVATION MECHANISM OF CASPASE PROTEIN: AN IN SILICO APPROACH
  door: KHAN, MD. ARIF
  Gepubliceerd in: (2019)
• IDENTICATION OF ANTICANCER DRUG THROUGH STUDYING THE ACTIVATION MECHANISM OF CASPASE PROTEIN: AN IN SILICO APPROACH /
  door: Khan, Md. Arif
  Gepubliceerd in: (2018)
• Inside the FDA : the business and politics behind the drugs we take and the food we eat /
  door: Hawthorne, Fran
  Gepubliceerd in: (2005)
• AN INTEGRATED TRANSCRIPTOMIC APPROACH TO IMMUNE PROFILING, HUB GENE DETECTION, AND IDENTIFICATION OF REPURPOSABLE DRUGS IN PANCREATIC CANCER /
  door: Fatema Jannat
  Gepubliceerd in: (2026)
• AN IN-SILICO APPROACH TO COMPARE MUTANT E PROTEIN STRUCTURE BETWEEN OLD AND RECENT DENGUE VIRUS EPISODES /
  door: SAJIB, JAYEM HASAN
  Gepubliceerd in: (2025)